Syria - Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis
Since 2014, Syria Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis jumped by 18.5points year on year. In 2019, the country was number 33 comparing other countries in Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis with 98 Percent. Norway ranked the highest with 108 Percent in 2019, that is a growth of 2.9points compared to 2018. Austria, Burundi and Marshall Islands respectively ranked number 2, 3 and 4 in this ranking. Equatorial Guinea recorded the best 5 years average growth at +34.3points per year, while United Arab Emirates recorded the worst performance at -100points per year.
Loading...
| Date | Percent |
|---|---|
| 2019 | 98.00 |
| 2018 | 95.00 |
| 2017 | 92.00 |
| 2016 | 89.00 |
| 2015 | 100.00 |
Download all data from 2002 to 2019
How does Syria rank in Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis?
| # | 313 Countries | Percent | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Norway
|
108.00 % | 2019 | +2.9 % | +3.7 % | View data | |
| 2 |
#2
Austria
|
107.00 % | 2019 | +4.9 % | +11.2 % | View data | |
| 33 |
#33
New Zealand
|
98.00 % | 2019 | +3.2 % | +24.3 % | View data | |
| 33 |
#33
Syria
|
98.00 % | 2019 | +3.2 % | +18.5 % | View data | |
| 37 |
#37
Benin
|
97.00 % | 2019 | +0.0 % | +2.9 % | View data | |